June 1, 2010 (San Francisco, California) — Transurethral resection of the prostate (TURP) seems to be a better treatment option than medical therapy for patients with benign prostatic hyperplasia (BPH ...
BOSTON and YOKNEAM, Israel, April 22, 2025 /PRNewswire/ -- Butterfly Medical, a medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), announced ...
PORTSMOUTH, N.H., Oct. 28, 2024 /PRNewswire/ -- Leading diagnostic and therapeutic medical technology company, Laborie Medical Technologies Corp (Laborie), announced today that the American Medical ...
TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable ...
The goals of therapy for BPH are to ameliorate LUTS, prevent related complications, and achieve measurable improvement in the patient's QOL. 3 In addition to drug and resource utilization costs, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback